BURIONI, ROBERTO
 Distribuzione geografica
Continente #
EU - Europa 1.141
NA - Nord America 643
AS - Asia 253
SA - Sud America 6
OC - Oceania 5
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.050
Nazione #
US - Stati Uniti d'America 638
SE - Svezia 612
IT - Italia 268
SG - Singapore 151
RU - Federazione Russa 142
CN - Cina 80
FI - Finlandia 42
DE - Germania 24
IE - Irlanda 21
IN - India 10
FR - Francia 9
RO - Romania 9
GB - Regno Unito 6
SA - Arabia Saudita 6
CA - Canada 5
AU - Australia 4
BR - Brasile 4
NL - Olanda 4
IR - Iran 3
EC - Ecuador 2
HK - Hong Kong 2
IS - Islanda 2
CH - Svizzera 1
EU - Europa 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PL - Polonia 1
ZA - Sudafrica 1
Totale 2.050
Città #
Princeton 171
Lawrence 168
Milan 88
Singapore 88
Ashburn 80
Shanghai 74
Moscow 61
New York 45
Helsinki 41
Bologna 25
Dublin 21
Boardman 19
Rome 16
Pune 10
Seattle 10
Marino 8
Washington 6
Borås 5
Jeddah 5
London 5
Turin 5
Los Angeles 4
Toronto 4
Xi'an 4
Ancona 3
Campagna 3
Catania 3
Ferrara 3
Frankfurt Am Main 3
Melbourne 3
Riccione 3
Sorocaba 3
South San Francisco 3
Verona 3
Bari 2
Bergamo 2
Castrovillari 2
Cenaia 2
Gatchina 2
Genoa 2
Naaldwijk 2
Paderno Dugnano 2
Pomigliano d'Arco 2
Pratola Peligna 2
Quarto 2
Quito 2
Reykjavik 2
Rockville 2
Seregno 2
Stimigliano 2
Torre Annunziata 2
Vedelago 2
Bisceglie 1
Bloemfontein 1
Brescia 1
Candia 1
Central 1
Chieti 1
Cornate d'Adda 1
Fasano 1
Florence 1
Hamilton 1
Hanover 1
Karachi 1
Krimpen Aan Den Ijssel 1
Kwai Chung 1
Lappeenranta 1
Legnano 1
Littleton 1
Lübeck 1
Macerata 1
Manassas 1
Mazzano Romano 1
Metairie 1
Mountain View 1
Napoli 1
Nardò 1
Nuoro 1
Omsk 1
Padova 1
Pinehaven 1
Redwood City 1
Rende 1
Rho 1
Riverside 1
Riyadh 1
Rotterdam 1
Rovellasca 1
San Mateo 1
Segrate 1
Sheffield 1
St Petersburg 1
Sydney 1
São Paulo 1
Tehran 1
Teramo 1
Terni 1
Trieste 1
Venice 1
Volgograd 1
Totale 1.077
Nome #
Salute : Le frontiere della medicina : Volumi dedicati alla Salute a cura di Roberto Burioni 127
Cell-to-cell spread-blocking activity is extremely limited in the sera of HSV-1 and HSV-2 infected subjects 37
Differential composition of vaginal microbiome, but not of seminal microbiome, is associated with successful intrauterine insemination in couples with idiopathic infertility: A prospective observational study 33
Virus, la grande sfida : dal coronavirus alla peste : come la scienza può salvare l'umanità / Roberto Burioni ; con la collaborazione di Pier Luigi Lopalco 33
Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: Epitope definition and implications in risk stratification of patients under natalizumab therapy 30
Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge 26
A Biologically-validated HCV E1E2 Heterodimer Structural Model 26
"Freezing" parasites in pre-Himalayan region, Himachal Pradesh: Experience with mini-FLOTAC 24
A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses 23
A phage display vector optimized for the generation of human antibody combinatorial libraries and the molecular cloning of monoclonal antibody fragments 23
Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro 23
Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols 22
66. Vaccini antivirali 21
Bacteriophages and Their Immunological Applications against Infectious Threats 21
Broadly neutralizing anti-influenza human monoclonal antibodies and their possible role in predictive medicine 21
Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes 21
A Human Stem Cell-Derived Neurosensory–Epithelial Circuitry on a Chip to Model Herpes Simplex Virus Reactivation 20
Characterization of two human monoclonal anti-E2/HCV antibodies for potential application in prevention and treatment of HCV infection 20
A Human Monoclonal Antibody with Neutralizing Activity against Highly Divergent Influenza Subtypes 20
Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects 20
A potential role for monoclonal antibodies in prophylactic and therapeutic treatment of influenza 19
SARS-CoV-2 before and after Omicron: two different viruses and two different diseases? 18
HUMAN MONOCLONAL ANTIBODY ENDOWED WITH ANTI-HSV-1 AND -2 ACTIVITY STRONGLY INHIBITS VIRUS REPLICATION 18
Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections 18
Interferon-β 1a inhibits SARS-CoV-2 in vitro when administered after virus infection 18
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein 18
Major sports events and the transmission of sars-cov-2: Analysis of seven case-studies in europe 18
Anti-idiotype monoclonal antibodies as mimotopes of the HIV gp120 antigen 17
Early molecular diagnosis of aspergillosis in a patient with acute myeloid leukaemia 17
ANTI-HIV-1 RESPONSE ELICITED IN RABBITS BY ANTI-IDIOTYPE MONOCLONAL ANTIBODIES MIMICKING THE CD4-BINDING SITE ON GP120 17
Answer to February 2019 Photo Quiz: Neurological Symptoms in a 74-Year-Old Diabetic Woman Admitted to the Emergency Room 17
A vector for the expression of recombinant monoclonal Fab fragments in bacteria 16
Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines 16
Antigen-driven evolution of B lymphocytes in coronary atherosclerotic plaques 16
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion? 16
Acute respiratory distress in a neutropenic febrile patient after hematopoietic cell transplantation 16
36. Meccanismi difensivi dell'ospite alle infezioni virali 16
63. Vaccini Antivirali 16
Epitope mapping by epitope excision, hydrogen/deuterium exchange, and peptide-panning techniques combined with in silico analysis 16
IN VIVO PROTECTION CONFERRED BY HUMAN MONOCLONAL ANTIBODY DIRECTED AGAINST HSV-1 AND 2 16
Anti-HIV-1 response elicited in rabbits by anti-idiotype monoclonal antibodies mimicking the CD4-binding site 15
Anti-HCV monoclonal antibody as a medicament for the therapeutic treatment and prevention of HCV infections 15
Monoclonal antibodies as a medicament for the therapeutic and/or prophylactic treatment of swine-origin influenza A (H1N1) virus (S-OIV) infections 15
Phage display for the production of human monoclonal antibodies against human pathogens 15
Global and local envelope protein dynamics of hepatitis C virus determine broad antibody sensitivity 15
Photo quiz: Neurological symptoms in a 74-year-old diabetic woman admitted to the emergency room 15
Molecular characterization of the human neutralizing response against hepatitis C virus and its role in the prediction of the infection outcome 15
A new subtraction technique for molecular cloning of rare antiviral antibody specificities from phage display libraries 14
Human monoclonal recombinant antibody against NS3 HCV protein and methods therefor 14
HCV E2 core structures and mAbs: something is still missing 14
Anti-HCV monoclonal antibody as a medicament for the therapeutic treatment and prevention of HCV infections 14
A recombinant human Fab inhibits helicase activity of HCVNS3 and negative strand RNA synthesis 14
Synergy evaluation of anti-Herpes Simplex Virus type 1 and 2 compounds acting on different steps of virus life cycle 14
Role and potential therapeutic use of antibodies against herpetic infections 14
Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools 13
A novel expression vector for production of epitope-tagged recombinant Fab-fragment in bacteria 13
39 Meccanismi difensivi dell'ospite alle infezioni virali 13
A closer look at prion strains: Characterization and important implications 13
Enteric microbiome markers as early predictors of clinical outcome in allogeneic hematopoietic stem cell transplant (allo-HSCT): results of a prospective study in adult patients 13
Molecular study and epitope mapping of the human antibody response against HCV/E2 glycoprotein by generation of monoclonal recombinant Fabs. 13
Structural basis for a human broadly neutralizing influenza A hemagglutinin stem-specific antibody including H17/18 subtypes 12
A novel efflux system in inducibly erythromycin-resistant strains of Streptococcus pyogenes 12
An improved phage display vector for antibody repertoire cloning by construction of combinatorial libraries 12
Capitolo 39 Meccanismi difensivi dell'ospite alle infezioni virali 12
HUMAN MONOCLONAL ANTIBODIES TO HERPES SIMPLEX VIRUS AND METHODS THEREFOR 12
Human Monoclonal Antibody Fab Fragments directed against HCV E2 glycoprotein and endowed with neutralizing activity 12
Monoclonal antibodies having homosubtype cross-neutralization properties against influenza A viruses subtype H1 12
Comparative Evaluation of the Bruker Biotyper and Vitek MS Matrix-Assisted Laser Desorption Ionization–Time Of Flight (MALDI-TOF) Mass Spectrometry Systems for Identification of Yeasts of Medical Importance 12
Phage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogens 12
Anticorpo monoclonale diretto contro il virus JC 12
Hepatitis C virus (HCV)-driven stimulation of subfamily-restricted natural IgM antibodies in mixed cryoglobulinemia 12
Has SARS-CoV-2 reached peak fitness? 12
Omeopatia : bugie, leggende e verità 12
Assessing the human immune response to SARS-CoV-2 variants 12
Intracellular expression of recombinant human immunoglobulin (IGGI) against NS3 inhibits helicase activity and HCV replication in cell culture 11
A recombinant human Fab inhibits activity of HCVNS3 and negative strand RNA synthesis 11
Heterogeneity of the humoral anti-HCV/E2 response in persistently infected patients as demonstrated by divergent patterns of inhibition of the binding of anti-HCV/E2 human monoclonal antibodies 11
Cost-effectiveness of blood culture and a multiplex real-time PCR in hematological patients with suspected sepsis: an observational propensity score-matched study 11
Molecular Diagnosis of Scedosporium apiospermum Keratitis. 11
Method for the preparation of new oligoclonal antibodies 11
Potential role of the detection of enterobacterial DNA in blood for the management of neonatal necrotizing enterocolitis 11
Risks of "blind" automated identification systems in medical microbiology 11
A NEW PLASMID CLONING VECTOR FOR DIRECT-DETECTION OF RECOMBINANT CLONES, BASED ON INACTIVATION OF A BACTERIAL ACID PHOSPHATASE-ENCODING GENE 11
A recombinant human Fab inhibits helicase activity of HCVNS3 and negative strand RNA synthesis 11
Divergent Trends of Anti-JCPyV Serum Reactivity and Neutralizing Activity in Multiple Sclerosis (MS) Patients during Treatment with Natalizumab 11
Correspondence: Italy's policy shift on immunization 11
Direct sequencing of Scedosporium apiospermum DNA in the diagnosis of a case of keratitis 11
La formidabile impresa. La medicina dopo la rivoluzione mRNA 10
Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs 10
Heterosubtypic protection conferred by the human monoclonal antibody PN-SIA28 against influenza A virus lethal infections in mice 10
Evaluation of resistance against bacterial microleakage of a new conical implant-abutment connection versus conventional connections: an in vitro study. 10
Monoclonal antibodies isolated from human B cells neutralize a broad range of H1 subtype influenza A viruses including swine-origin Influenza virus (S-OIV) 10
Phage Display Technology 10
Possible future monoclonal antibody (mAb)-based therapy against arbovirus infections 10
Humoral immune response against hepatitis C virus 10
Blocking immunodominant epitopes by competitive deselection. 10
Quantitation of Bacillus clausii in biological samples by real-time polymerase chain reaction 10
Natalizumab-Associated Progressive Multifocal Leukoencephalopathy 10
Hepatitis C virus (HCV) infection may elicit neutralizing antibodies targeting epitopes conserved in all viral genotypes 9
Inhibition of HCV-NS3 helicase activity and negative strand RNA syntesis by intracelllular expression of a recombinant human anti-NS3 Fab 9
Totale 1.650
Categoria #
all - tutte 33.299
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.299


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202020 14 0 0 0 0 0 5 0 0 0 0 1
2020/202113 4 0 0 3 3 1 1 0 0 1 0 0
2021/2022142 0 0 7 41 6 3 17 14 6 27 7 14
2022/20231.104 387 281 95 11 11 135 48 56 55 3 14 8
2023/2024530 24 38 79 62 29 100 11 43 4 38 19 83
2024/2025273 273 0 0 0 0 0 0 0 0 0 0 0
Totale 2.194